September 06, 2025 a 01:01 pm
ISRG: Analysts Ratings - Intuitive Surgical, Inc.
Intuitive Surgical, Inc. continues to exhibit solid performance in the minimally invasive surgical market. Their flagship product, the da Vinci Surgical System, remains a leader in innovative surgical solutions. While recent analyst recommendations reflect stability, slight variations hint at potential sentiment shifts in the near future.
Historical Stock Grades
The analyst ratings for Intuitive Surgical, Inc. as of September 2025 show a consistent interest, with a notable focus on "Buy" and "Strong Buy" recommendations. The current distribution reflects an optimistic outlook on the company's future growth.
| Rating | Count | Score |
|---|---|---|
| Strong Buy | 7 | |
| Buy | 15 | |
| Hold | 8 | |
| Sell | 1 | |
| Strong Sell | 1 |
Sentiment Development
Over the past few months, Intuitive Surgical, Inc.'s analyst sentiments have shown remarkable stability, with minor shifts in specific categories:
- A slight decrease in "Strong Buy" ratings, especially from July 2025.
- "Hold" ratings showed inconsistency, briefly spiking in August.
- A steady number of "Sell" and "Strong Sell" ratings indicates caution.
Percentage Trends
While maintaining predominantly positive sentiment, key shifts in the percentage distribution of analyst ratings for ISRG are noteworthy:
- "Strong Buy" ratings decreased from 40% in February to 28% by September 2025.
- "Hold" ratings saw a minor increase in percentage share.
- The consistent "Sell" and "Strong Sell" categories suggest heightened caution, albeit still minimal.
- The past year highlights an increase in conservative recommendations, with a subtle shift towards caution by the latter half of 2025.
Latest Analyst Recommendations
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-08-19 | Outperform | Outperform | RBC Capital |
| 2025-07-23 | Neutral | Neutral | UBS |
| 2025-07-23 | Overweight | Overweight | Piper Sandler |
| 2025-07-23 | Outperform | Outperform | RBC Capital |
| 2025-07-23 | Buy | Buy | Truist Securities |
Analyst Recommendations with Change of Opinion
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-06-09 | Sell | Hold | Deutsche Bank |
| 2024-12-02 | Overweight | Equal Weight | Morgan Stanley |
| 2024-11-19 | Buy | Hold | Erste Group |
| 2024-08-02 | Buy | Neutral | Redburn Atlantic |
| 2022-02-02 | Buy | Neutral | UBS |
Interpretation
The market sentiment towards Intuitive Surgical, Inc. remains largely positive, with a significant proportion of "Buy" ratings. However, the incremental increase in "Hold" and "Sell" recommendations could signal a growing sense of caution among analysts. These variations may suggest a stabilizing trend, reflecting external market conditions or future uncertainties. Overall, the consistency in ratings implies that analyst confidence in Intuitive Surgical's strategic direction and product innovation continues broadly intact.
Conclusion
Intuitive Surgical, Inc. retains a strong market position, bolstered by sustained analyst confidence as reflected in prevalent "Buy" recommendations. Nonetheless, emerging cautionary trends, as indicated by minor shifts towards "Hold" and "Sell" ratings, highlight potential market challenges. The company remains fundamentally robust, yet monitoring these sentiment fluctuations is vital for stakeholders, as subtle shifts may foretell broader market movements or corporate developments impacts on analyst perspectives.